Dr. Emerson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
15 Penn Tower
Philadelphia, PA 19104Phone+1 215-662-3914
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1984 - 1985
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1983 - 1985
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1982 - 1985
- Massachusetts General HospitalResidency, Internal Medicine, 1980 - 1982
- Yale UniversityPhD, Cell Biology & Immunology, 1976 - 1980
- Yale School of MedicineClass of 1980
- Yale UniversityMSc, Molecular Biophysics & Biochemistry, 1974 - 1976
- Haverford CollegeBA, Chemistry & Philosophy, Summa Cum Laude, 1970 - 1974
Certifications & Licensure
- NY State Medical License 2013 - 2024
- PA State Medical License 1994 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Elected Member Association of American Physicians, 2000
- Chevalier of the French Legion of Honor 2012
- Wilbur Cross Medal Yale University, 2008
- Join now to see all
Publications & Presentations
PubMed
- 21 citationsDecreased Naïve T-cell Production Leading to Cytokine Storm as Cause of Increased COVID-19 Severity with Comorbidities.Michael D Schwartz, Stephen G. Emerson, Jennifer A. Punt, Willow D Goff
Aging and Disease. 2020-07-23 - 9 citationsIdentification of a Multipotent Progenitor Population in the Spleen That Is Regulated by NR4A1.Melanie Mumau, Ashley N. Vanderbeck, Elizabeth D. Lynch, Sophia B. Golec, Stephen G. Emerson
Journal of Immunology. 2018-02-01 - 51 citationsClinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxisRyan H. Moy, Austin P. Huffman, Lee P. Richman, Lisa Crisalli, Ximi K. Wang
Blood. 2017-02-16
Journal Articles
- Long-term functional engraftment of mesenchymal progenitor cells in a mouse model of accelerated agingSingh, L., Brennan, T.A., Kim J.-H., Egan, K.P., McMillan, E.A., Chen, Q., Hankenson, K.D., Zhang, Y., Emerson, S.G., Johnson, F.B., Pignolo, R.J., Stem Cells, 1/1/2013
- NF-Y is a Key Regulator of Hematopoietic Stem Cell (HSC) regulatory genes and isEssential for Cycling but not Quiescent HSCsBungartz , B., Land H., Scadden, D.T., Emerson, S.G., Blood, 1/1/2012
- Prevention of Graft-versus-Host Disease by Blocking Lymphocyte ChemotaxisReshef, R., Luger, S.M., Hexner, E.O., Loren, A.W., Frey, N.V., Nasta, S.D., Goldstein, S.C. Stadtmauer, E.A. Smith, J., Bailey, S., Mick, R., Heitjan, D.F., Emerson, ..., NEJM, 1/1/2012
- Join now to see all
Books/Book Chapters
Lectures
- “Stem Cells and the Immune System.”University of Michigan, Ann Arbor, MI - 9/15/2013
- “The Future of Cancer Centers as Organizers of Health Care Delivery.”Roswell Park Memorial Institute, Buffalo, NY - 6/14/2013
- Commencement Address.Shipley School, Bryn Mawr, PA - 6/6/2011
- Join now to see all
Other
- Reponse. In, “Remise d’une letter de Descartes au Pere Marin Mersenne (1641) a la Bibliotheque de l’Institut de France par Haverford College.Emerson, S.G., Palais de L’institut
1/1/2010 - Radiolabeling of p-Bz-DOTA-CD-11c antibody with 88Y: Conjugation, Labeling, Biodistribution studies.Brockmann, J., Maus, S., Senekowitsch-Schmidtke, R., Wester, H.J, Emerson, S.G., Rosch, F., Kemchemie Univ. Mainz.
1/1/2000 - The turnover and shedding of cell membrane proteins by murine spleen cells in culture. (Doctoral Dissertation)Emerson, S.G., Yale University
1/1/1980 - Join now to see all
Press Mentions
- Cancer Center at 50December 23rd, 2021
- Dr. Brian Marr Appointed Director of Ophthalmic Oncology at NewYork-Presbyterian/Columbia University Medical CenterMay 10th, 2017
- NewYork-Presbyterian, Columbia University Medical Center and Weill Cornell Medicine Among the Nation's Cancer Centers Endorsing HPV Vaccination for Cancer PreventionJanuary 27th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: